iBio, Inc. (IBIO) PT Lowered to $1.60 at Brookline Capital Markets
Tweet Send to a Friend
Brookline Capital Markets analyst Kemp Dolliver lowered the price target on iBio, Inc. (NASDAQ: IBIO) to $1.60 (from $3.60) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
